Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Carcinogenesis

Targeted disruption of signal transducer and activator of transcription 3 (Stat3) in bulge region keratinocyte stem cells inhibits chemically-induced skin carcinogenesis

Dae Kim, Ken Kataoka, George Cotsarelis and John DiGiovanni
Dae Kim
UT M.D. Anderson Cancer Ctr., Smithville, TX, University of Pennsylvania School of Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Kataoka
UT M.D. Anderson Cancer Ctr., Smithville, TX, University of Pennsylvania School of Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Cotsarelis
UT M.D. Anderson Cancer Ctr., Smithville, TX, University of Pennsylvania School of Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John DiGiovanni
UT M.D. Anderson Cancer Ctr., Smithville, TX, University of Pennsylvania School of Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2008
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 12-16, 2008; San Diego, CA

Abstract

2501

Keratinoctye stem cells (KSCs) located in the bulge region of hair follicles are self-renewing cells that have slowly cycling and quiescent characteristics. KSCs maintain hair growth and epidermal homeostasis by providing transit amplifying cells that differentiate into cutaneous lineage cells. Studies focusing on KSCs as the origin of skin tumors have suggested that KSCs, especially those in the bulge region of hair follicles, could be a potential target of skin carcinogenesis. Recently, we have shown that Stat3 is required for both the initiation and promotion stages of skin carcinogenesis. During initiation, Stat3 appears to be critical for survival of DNA-damaged keratinocytes, especially those found in the bulge region. During tumor promotion, Stat3 appears to be critical for proliferation of keratinocytes and clonal expansion of initiated cells. To determine functional roles of Stat3 in bulge region KSC survival and proliferation during skin carcinogenesis, we generated inducible bulge region KSC-specific Stat3 deficient mice (K15.CrePR1.Stat3fl/fl mice) that allow targeted disruption of Stat3 in KSCs following RU486 treatment. Following treatment with DMBA, Ha-ras codon 61 A182→T mutations were significantly decreased in bulge region KSCs isolated from K15.CrePR1.Stat3fl/fl mice treated with RU486 compared with those of nontransgenic littermates. In addition, inducible deletion of Stat3 prior to DMBA treatment significantly increased the number of apoptotic keratinocytes in the bulge region compared with nontransgenic littermates. Furthermore, following treatment with TPA, α6- and CD34-positive KSCs isolated from hair follicles of K15.CrePR1.Stat3fl/fl mice treated with RU486 showed reduced proliferative response compared with those of nontransgenic littermates, as analyzed by FACS. In two-stage skin carcinogenesis experiments, both tumor incidence and the average number of papillomas per mouse were significantly reduced (~80% reduction in the average number of papillomas per mouse) in K15.CrePR1.Stat3fl/fl mice treated with RU486 prior to initiation compared with similarly treated control mice. Collectively, these results provide strong evidence that Stat3 is required for survival of bulge region KSCs during initiation with DMBA. These data also support the hypothesis that bulge region KSCs contribute significantly to skin tumor development in this model of epithelial carcinogenesis.

Footnotes

  • 99th AACR Annual Meeting-- Apr 12-16, 2008; San Diego, CA

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 68 (9 Supplement)
May 2008
Volume 68, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Targeted disruption of signal transducer and activator of transcription 3 (Stat3) in bulge region keratinocyte stem cells inhibits chemically-induced skin carcinogenesis
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Targeted disruption of signal transducer and activator of transcription 3 (Stat3) in bulge region keratinocyte stem cells inhibits chemically-induced skin carcinogenesis
Dae Kim, Ken Kataoka, George Cotsarelis and John DiGiovanni
Cancer Res May 1 2008 (68) (9 Supplement) 2501;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Targeted disruption of signal transducer and activator of transcription 3 (Stat3) in bulge region keratinocyte stem cells inhibits chemically-induced skin carcinogenesis
Dae Kim, Ken Kataoka, George Cotsarelis and John DiGiovanni
Cancer Res May 1 2008 (68) (9 Supplement) 2501;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Carcinogenesis

  • Abstract LB-087: A facilitative role for caspase 3 in promoting genetic instability and carcinogenesis
  • Abstract LB-090: Estrogen metabolism within the human lung: impact of tumorigenesis, tobacco smoke, gender and race
  • Abstract LB-091: Characterization of molecular changes occurring during long-term treatment of human bronchial epithelial cells with cigarette smoke total particulate matter
Show more 3

Molecular Mechanisms of Carcinogenesis: Oral Presentations - Proffered Abstracts

  • High frequency mitochondrial DNA somatic mutations and its association to sex hormone receptors and TP53 gene mutations in breast cancer
  • Site selectivity of p53 cysteine thiol modification by 15-deoxy-Δ12,14-prostaglandin J2: Implications for functional inactivation of p53
  • Fatty Acid Synthase (FASN) promotes transformation of normal breast epithelial cells: a novel metabolic oncogene?
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement